Skinful of money

University of Sydney spin-off Elastagen has been sold to pharma company Allergan for US$95m, with further payments if the technology reaches the market. Elastagen is a synthetic spray-on skin for use in surgical wound repair and scar remodelling. The company was founded by UniSyd biochemist Tony Weiss.


to get daily updates on what's happening in the world of Australian Higher Education